Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Keruide Pharmaceutical is a specialized Chinese pharmaceutical company focused on the central nervous system (CNS) therapeutic area. Founded in 2000, the company integrates research, development, manufacturing, and commercialization of both innovative drugs and high-end generics. Its core product portfolio includes treatments for epilepsy, anxiety, and anesthesia, with several products maintaining significant market share in China. Keruide operates a comprehensive R&D center in Chengdu and a large-scale manufacturing base in Luzhou. The company is recognized for its technical expertise in complex formulations and small molecule synthesis, aiming to address unmet needs in mental health and neurological disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Keruide Pharmaceutical.